469 related articles for article (PubMed ID: 24597598)
1. Vitamin D and vitamin D receptor activators in treatment of hypertension and cardiovascular disease.
Franczyk A; Stolarz-Skrzypek K; WesoĊowska A; Czarnecka D
Cardiovasc Hematol Disord Drug Targets; 2014; 14(1):34-44. PubMed ID: 24597598
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular disease in chronic kidney failure: the role of VDR activators.
Wu-Wong JR; Tian J; Nakane M; Ma J; Fey TA; Kroeger P; Fryer RM; Reinhart GA
Curr Opin Investig Drugs; 2006 Mar; 7(3):206-13. PubMed ID: 16555680
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D and Vitamin D Receptor: New Insights in the Treatment of Hypertension.
Lin L; Zhang L; Li C; Gai Z; Li Y
Curr Protein Pept Sci; 2019; 20(10):984-995. PubMed ID: 31389312
[TBL] [Abstract][Full Text] [Related]
4. The potential for vitamin D receptor activation in cardiovascular research.
Wu-Wong JR
Expert Opin Investig Drugs; 2007 Apr; 16(4):407-11. PubMed ID: 17371189
[TBL] [Abstract][Full Text] [Related]
5. Potential for vitamin D receptor agonists in the treatment of cardiovascular disease.
Wu-Wong JR
Br J Pharmacol; 2009 Sep; 158(2):395-412. PubMed ID: 19371337
[TBL] [Abstract][Full Text] [Related]
6. Role of vitamin D in cardiovascular disease.
Verhave G; Siegert CE
Neth J Med; 2010 Mar; 68(3):113-8. PubMed ID: 20308705
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D and cardiovascular disease.
Norman PE; Powell JT
Circ Res; 2014 Jan; 114(2):379-93. PubMed ID: 24436433
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D and Cardiovascular Disease, with Emphasis on Hypertension, Atherosclerosis, and Heart Failure.
Latic N; Erben RG
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899880
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D resistance.
Bouillon R; Verstuyf A; Mathieu C; Van Cromphaut S; Masuyama R; Dehaes P; Carmeliet G
Best Pract Res Clin Endocrinol Metab; 2006 Dec; 20(4):627-45. PubMed ID: 17161336
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D and the heart.
Gardner DG; Chen S; Glenn DJ
Am J Physiol Regul Integr Comp Physiol; 2013 Nov; 305(9):R969-77. PubMed ID: 24026071
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic applications for novel non-hypercalcemic vitamin D receptor ligands.
Choi M; Makishima M
Expert Opin Ther Pat; 2009 May; 19(5):593-606. PubMed ID: 19441936
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D and human health: lessons from vitamin D receptor null mice.
Bouillon R; Carmeliet G; Verlinden L; van Etten E; Verstuyf A; Luderer HF; Lieben L; Mathieu C; Demay M
Endocr Rev; 2008 Oct; 29(6):726-76. PubMed ID: 18694980
[TBL] [Abstract][Full Text] [Related]
13. [Current Topics on Vitamin D. Nonsecosteroidal vitamin D mudulators and prospects for their thepapeutic application].
Makishima M
Clin Calcium; 2015 Mar; 25(3):403-11. PubMed ID: 25716814
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular disease in chronic kidney failure: is there a role for vitamin D analogs?
Wu-Wong JR; Nakane M; Traylor L; Ruan X; Kroeger PE; Tian J
Curr Opin Investig Drugs; 2005 Mar; 6(3):245-54. PubMed ID: 15816500
[TBL] [Abstract][Full Text] [Related]
15. Are vitamin D receptor activators useful for the treatment of thrombosis?
Wu-Wong JR
Curr Opin Investig Drugs; 2009 Sep; 10(9):919-27. PubMed ID: 19705334
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D receptor activator selectivity in the treatment of secondary hyperparathyroidism: understanding the differences among therapies.
Brancaccio D; Bommer J; Coyne D
Drugs; 2007; 67(14):1981-98. PubMed ID: 17883283
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D.
Dusso AS; Brown AJ; Slatopolsky E
Am J Physiol Renal Physiol; 2005 Jul; 289(1):F8-28. PubMed ID: 15951480
[TBL] [Abstract][Full Text] [Related]
18. Effects of vitamin D analogs on the expression of plasminogen activator inhibitor-1 in human vascular cells.
Wu-Wong JR; Nakane M; Ma J
Thromb Res; 2006; 118(6):709-14. PubMed ID: 16371233
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D in chronic kidney disease: a systemic role for selective vitamin D receptor activation.
Andress DL
Kidney Int; 2006 Jan; 69(1):33-43. PubMed ID: 16374421
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D analogs modulate the expression of plasminogen activator inhibitor-1, thrombospondin-1 and thrombomodulin in human aortic smooth muscle cells.
Wu-Wong JR; Nakane M; Ma J
J Vasc Res; 2007; 44(1):11-8. PubMed ID: 17159355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
